Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

      USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

      Medical Dialogues Bureau21 April 2019 9:27 AM IST
      The U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
      Second death in Novartis gene therapy trials under investigation

      Second death in Novartis gene therapy trials under investigation

      Medical Dialogues Bureau20 April 2019 12:29 PM IST
      Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular atrophy, on Friday said...
      USFDA outlines consideration on medical devices containing metal alloy nitinol

      USFDA outlines consideration on medical devices containing metal alloy nitinol

      Medical Dialogues Bureau20 April 2019 9:15 AM IST
      U.S: The U.S. Food and Drug Administration recently published a draft guidance titled, “Technical Considerations for Non-Clinical Assessment of...
      Setback to Boston Scientific: Over Rs 173 crore hit to 2019 revenue from mesh withdrawal

      Setback to Boston Scientific: Over Rs 173 crore hit to 2019 revenue from mesh withdrawal

      Medical Dialogues Bureau19 April 2019 9:30 AM IST
      The company said it will continue to assess any potential additional impact to the business due to the FDA’s decision that applies to two of Boston...
      Recordati to seek Canadian approval for kidney disease drug Cystagon

      Recordati to seek Canadian approval for kidney disease drug Cystagon

      Medical Dialogues Bureau17 April 2019 9:08 AM IST
      In 2017, Horizon won Health Canada's approval for Procysbi, making it much harder for Canadian patients to access Cystagon.TORONTO: Italy's Recordati...
      Wockhardt gets zero USFDA observations for Bioequivalence centre

      Wockhardt gets zero USFDA observations for Bioequivalence centre

      Medical Dialogues Bureau16 April 2019 9:31 AM IST
      Bioequivalence studies of Tamsulosin 0.4mg capsules and Metoprolol Tartrate 200mg ER tablets were audited, Wockhardt had reported.New Delhi: Shares of...
      Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity

      Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity

      Medical Dialogues Bureau16 April 2019 9:30 AM IST
      The U.S. Food and Drug Administration last week approved Amgen Inc's bone-building Evenity for postmenopausal women who are at high risk of fracture...
      Jubilant Life Sciences arm recalls 12960 bottles of Pantoprazole Sodium delayed release tablets

      Jubilant Life Sciences arm recalls 12960 bottles of Pantoprazole Sodium delayed release tablets

      Medical Dialogues Bureau15 April 2019 9:45 AM IST
      The reason for the recall of 2,960 bottles of Pantoprazole Sodium delayed-release tablets by Jubilant Life Sciences' arm, Jubilant Cadista is...
      USFDA pulls up Walmart, Kroger, others for selling tobacco to minors

      USFDA pulls up Walmart, Kroger, others for selling tobacco to minors

      Medical Dialogues Bureau15 April 2019 9:00 AM IST
      U.S: The U.S. Food and Drug Administration (FDA) said on Friday it has sent letters to Walmart Inc, Kroger Co and 10 other convenience store chains...
      Clovis Oncology to discontinue mid-stage bladder cancer trial

      Clovis Oncology to discontinue mid-stage bladder cancer trial

      Medical Dialogues Bureau14 April 2019 9:15 AM IST
      However, Clovis Oncology said it would continue to test the drug, Rubraca, in combination with other treatments for bladder cancer.New Delhi: Clovis...
      Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

      Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

      Medical Dialogues Bureau12 April 2019 2:30 PM IST
      "Their nearly Rs 6,300 crore has been syphoned off by some 'baba'. These children have been duped," Kapil Sibal had said, adding that let the...
      Astrazeneca, Merck wins EU nod for Lynparza to treat breast cancer

      Astrazeneca, Merck wins EU nod for Lynparza to treat breast cancer

      Medical Dialogues Bureau12 April 2019 9:26 AM IST
      New Delhi: AstraZeneca and Merck & Co., Inc. (MSD) recently announced the European Commission (EC) has approved Lynparza (olaparib) as a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok